| IC 35-48-2-8 |
NARCOTIC NEWS
Drug Law in Indiana IC 35-48-2-8
Drug Law in Indiana IC 35-48-2-8
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Schedule III
Sec. 8. (a) The controlled substances listed in this section are included in
schedule III.
(b) Stimulants. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances having a stimulant effect on the central
nervous system, including its salts, isomers (whether optical, position, or
geometric), and salts of such isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
(1) Those compounds, mixtures, or preparations in dosage unit form
containing any stimulant substances listed in schedule II which compounds,
mixtures, or preparations were listed on April 1, 1986, as excepted compounds
under 21 CFR 1308.32, and any other drug of the quantitative composition
shown in that list for those drugs or that is the same except that it contains a
lesser quantity of controlled substances (1405).
(2) Benzphetamine (1228).
(3) Chlorphentermine (1645).
(4) Clortermine (1647).
(5) Phendimetrazine (1615).
(c) Depressants. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances having a depressant effect on the central
nervous system:
(1) Any compound, mixture, or preparation containing:
(A) amobarbital (2125);
(B) secobarbital (2315);
(C) pentobarbital (2270); or
(D) any of their salts;
and one (1) or more other active medicinal ingredients which are not listed in
any schedule.
(2) Any suppository dosage form containing:
(A) amobarbital (2125);
(B) secobarbital (2315);
(C) pentobarbital (2270); or
(D) any of their salts;
and approved by the Food and Drug Administration for marketing only as a
suppository.
(3) Any substance which contains any quantity of a derivative of barbituric acid,
or any salt thereof (2100).
(4) Chlorhexadol (2510).
(5) Glutethimide (2550).
(6) Lysergic acid (7300).
(7) Lysergic acid amide (7310).
(8) Methyprylon (2575).
(9) Sulfondiethylmethane (2600).
(10) Sulfonethylmethane (2605).
(11) Sulfonmethane (2610).
(12) A combination product containing tiletimine and zolazepam (Telazol)
(7295).
(13) Any drug product containing gamma-hydroxybutyric acid, including its salts,
isomers, and salts of isomers, for which an application is approved under
section 505 of the federal Food, Drug and Cosmetic Act, 21 U.S.C. 301 et seq.
(2012).
(d) Nalorphine (a narcotic drug) (9400).
(e) Narcotic Drugs. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation containing any of
the following narcotic drugs, or their salts calculated as the free anhydrous
base or alkaloid, in the following limited quantities:
(1) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
alkaloid of opium (9803).
(2) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90
milligrams per dosage unit, with one (1) or more active, nonnarcotic
ingredients in recognized therapeutic amounts (9804).
(3) Not more than 300 milligrams of dihydrocodeinone, per 100 milliliters or not
more than 15 milligrams per dosage unit, with a fourfold or greater quantity of
an isoquinoline alkaloid of opium (9805).
(4) Not more than 300 milligrams of dihydrocodeinone, per 100 milliliters or not
more than 15 milligrams per dosage unit, with one (1) or more active
nonnarcotic ingredients in recognized therapeutic amounts (9806).
(5) Not more than 1.8 grams of dihydrocodeine, per 100 milliliters or not more
than 90 milligrams per dosage unit, with one (1) or more active, nonnarcotic
ingredients in recognized therapeutic amounts (9807).
(6) Not more than 300 milligrams of ethylmorphine, per 100 milliliters or not
more than 15 milligrams per dosage unit, with one (1) or more active,
nonnarcotic ingredients in recognized therapeutic amounts (9808).
(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams
or not more than 25 milligrams per dosage unit, with one (1) or more active,
nonnarcotic ingredients in recognized therapeutic amounts (9809).
(8) Not more than 50 milligrams of morphine, per 100 milliliters or per 100
grams with one (1) or more active nonnarcotic ingredients in recognized
therapeutic amounts (9810).
(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21 U.S.C.
802(41)(B)).
(g) The board shall except by rule any compound, mixture, or preparation
containing any stimulant or depressant substance listed in subsections (b)
through (e) from the application of any part of this article if the compound,
mixture, or preparation contains one (1) or more active medicinal ingredients
not having a stimulant or depressant effect on the central nervous system, and
if the admixtures are included therein in combinations, quantity, proportion, or
concentration that vitiate the potential for abuse of the substances which have a
stimulant or depressant effect on the central nervous system.
(h) Any material, compound, mixture, or preparation which contains any quantity
of Ketamine.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.2, SEC.86;
Acts 1979, P.L.303, SEC.5; Acts 1981, P.L.170, SEC.4; P.L.333-1983, SEC.3;
P.L.200-1987, SEC.10; P.L.48-1991, SEC.76; P.L.1-1994, SEC.171;
P.L.31-1998, SEC.10; P.L.288-2001, SEC.16
schedule III.
(b) Stimulants. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances having a stimulant effect on the central
nervous system, including its salts, isomers (whether optical, position, or
geometric), and salts of such isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
(1) Those compounds, mixtures, or preparations in dosage unit form
containing any stimulant substances listed in schedule II which compounds,
mixtures, or preparations were listed on April 1, 1986, as excepted compounds
under 21 CFR 1308.32, and any other drug of the quantitative composition
shown in that list for those drugs or that is the same except that it contains a
lesser quantity of controlled substances (1405).
(2) Benzphetamine (1228).
(3) Chlorphentermine (1645).
(4) Clortermine (1647).
(5) Phendimetrazine (1615).
(c) Depressants. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances having a depressant effect on the central
nervous system:
(1) Any compound, mixture, or preparation containing:
(A) amobarbital (2125);
(B) secobarbital (2315);
(C) pentobarbital (2270); or
(D) any of their salts;
and one (1) or more other active medicinal ingredients which are not listed in
any schedule.
(2) Any suppository dosage form containing:
(A) amobarbital (2125);
(B) secobarbital (2315);
(C) pentobarbital (2270); or
(D) any of their salts;
and approved by the Food and Drug Administration for marketing only as a
suppository.
(3) Any substance which contains any quantity of a derivative of barbituric acid,
or any salt thereof (2100).
(4) Chlorhexadol (2510).
(5) Glutethimide (2550).
(6) Lysergic acid (7300).
(7) Lysergic acid amide (7310).
(8) Methyprylon (2575).
(9) Sulfondiethylmethane (2600).
(10) Sulfonethylmethane (2605).
(11) Sulfonmethane (2610).
(12) A combination product containing tiletimine and zolazepam (Telazol)
(7295).
(13) Any drug product containing gamma-hydroxybutyric acid, including its salts,
isomers, and salts of isomers, for which an application is approved under
section 505 of the federal Food, Drug and Cosmetic Act, 21 U.S.C. 301 et seq.
(2012).
(d) Nalorphine (a narcotic drug) (9400).
(e) Narcotic Drugs. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation containing any of
the following narcotic drugs, or their salts calculated as the free anhydrous
base or alkaloid, in the following limited quantities:
(1) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
alkaloid of opium (9803).
(2) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90
milligrams per dosage unit, with one (1) or more active, nonnarcotic
ingredients in recognized therapeutic amounts (9804).
(3) Not more than 300 milligrams of dihydrocodeinone, per 100 milliliters or not
more than 15 milligrams per dosage unit, with a fourfold or greater quantity of
an isoquinoline alkaloid of opium (9805).
(4) Not more than 300 milligrams of dihydrocodeinone, per 100 milliliters or not
more than 15 milligrams per dosage unit, with one (1) or more active
nonnarcotic ingredients in recognized therapeutic amounts (9806).
(5) Not more than 1.8 grams of dihydrocodeine, per 100 milliliters or not more
than 90 milligrams per dosage unit, with one (1) or more active, nonnarcotic
ingredients in recognized therapeutic amounts (9807).
(6) Not more than 300 milligrams of ethylmorphine, per 100 milliliters or not
more than 15 milligrams per dosage unit, with one (1) or more active,
nonnarcotic ingredients in recognized therapeutic amounts (9808).
(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams
or not more than 25 milligrams per dosage unit, with one (1) or more active,
nonnarcotic ingredients in recognized therapeutic amounts (9809).
(8) Not more than 50 milligrams of morphine, per 100 milliliters or per 100
grams with one (1) or more active nonnarcotic ingredients in recognized
therapeutic amounts (9810).
(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21 U.S.C.
802(41)(B)).
(g) The board shall except by rule any compound, mixture, or preparation
containing any stimulant or depressant substance listed in subsections (b)
through (e) from the application of any part of this article if the compound,
mixture, or preparation contains one (1) or more active medicinal ingredients
not having a stimulant or depressant effect on the central nervous system, and
if the admixtures are included therein in combinations, quantity, proportion, or
concentration that vitiate the potential for abuse of the substances which have a
stimulant or depressant effect on the central nervous system.
(h) Any material, compound, mixture, or preparation which contains any quantity
of Ketamine.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.2, SEC.86;
Acts 1979, P.L.303, SEC.5; Acts 1981, P.L.170, SEC.4; P.L.333-1983, SEC.3;
P.L.200-1987, SEC.10; P.L.48-1991, SEC.76; P.L.1-1994, SEC.171;
P.L.31-1998, SEC.10; P.L.288-2001, SEC.16